FDA Revokes Immucor's (BLUD) Biologics License with Respect to its Reagent Red Blood Cells and Anti-E Blood Grouping Reagent
Tweet Send to a Friend
Immucor, Inc., (Nasdaq: BLUD) announced that yesterday the Food and Drug Administration ("FDA"), in an administrative action based on an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
